Drug intelligence / Profile preview

Ezepeg

Development stage
Unknown
Lead developer
Mercury Laboratories
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

**Ezepeg** is a Mercury Laboratories gastrointestinal product brand rather than one uniquely defined active substance. It is marketed in at least two oral formulations: an Ezepeg powder containing polyethylene glycol 3350 for constipation, and a sugar-free orange-flavoured oral solution containing polyethylene glycol with sodium chloride, sodium bicarbonate, and potassium chloride for constipation relief and bowel cleansing before gastrointestinal procedures. Polyethylene glycol functions as an osmotic laxative by retaining water in the intestinal lumen, softening stool and promoting evacuation; the electrolyte-containing formulation is intended to help maintain fluid and electrolyte balance during bowel preparation. ([apollopharmacy.in](https://www.apollopharmacy.in/medicine/ezepeg-sugar-free-orange-flavour-oral-solution-200-ml))

Brand names
Ezepeg

Beyond the preview

Go deeper on Ezepeg.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ezepeg.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call